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Abstract
Background: Drugs of abuse elevate brain dopamine levels, and, in vivo, chronic drug use is accompanied by a selective
decrease in dopamine D2 receptor (D2R) availability in the brain. Such a decrease consequently alters the ratio of D1R:D2R
signaling towards the D1R. Despite a plethora of behavioral studies dedicated to the understanding of the role of dopamine
in addiction, a molecular mechanism responsible for the downregulation of the D2R, in vivo, in response to chronic drug use
has yet to be identified.
Methods and Findings: Ethics statement: All animal work was approved by the Gallo Center IACUC committee and was
performed in our AAALAC approved facility. In this study, we used wild type (WT) and G protein coupled receptor associated
sorting protein-1 (GASP-1) knock out (KO) mice to assess molecular changes that accompany cocaine sensitization. Here, we
show that downregulation of D2Rs or upregulation of D1Rs is associated with a sensitized locomotor response to an acute
injection of cocaine. Furthermore, we demonstrate that disruption of GASP-1, that targets D2Rs for degradation after
endocytosis, prevents cocaine-induced downregulation of D2Rs. As a consequence, mice with a GASP-1 disruption show a
reduction in the sensitized locomotor response to cocaine.
Conclusions: Together, our data suggests that changes in the ratio of the D1R:D2R could contribute to cocaine-induced
behavioral plasticity and demonstrates a role of GASP-1 in regulating both the levels of the D2R and cocaine sensitization.
Citation: Thompson D, Martini L, Whistler JL (2010) Altered Ratio of D1 and D2 Dopamine Receptors in Mouse Striatum Is Associated with Behavioral
Sensitization to Cocaine. PLoS ONE 5(6): e11038. doi:10.1371/journal.pone.0011038
Editor: Thomas Burne, University of Queensland, Australia
Received December 7, 2009; Accepted April 7, 2010; Published June 9, 2010
Copyright:  2010 Thompson et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by
funds provided to the state of California for medical research on alcohol and substance abuse through the University of California, San Francisco to J.L.W. and the
National Institute of Mental Health (NIMH, MH068442-01) to J.L.W. D.T. is supported in part by a NARSAD young investigator award. L.M. is supported by the
Danish Agency for Science and Technology and Innovation (Copenhagen, Denmark).
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: jwhistler@gallo.ucsf.edu
Introduction
Drugs of abuse cause long lasting alterations in dopaminergic
neurotransmission. Dopamine mediates its effects through its
action at five distinct receptors (D1, D2, D3, D4 and D5)
belonging to the G protein-coupled receptor (GPCR) superfamily.
These receptors can be subdivided into two groups: the D1-like
(D1 and D5), which are coupled to the stimulatory G proteins Gs
and Golf, and the D2-like (D2, D3, D4), which are coupled to the
inhibitory G proteins Gi/o. Disruptions in dopaminergic signaling
have been implicated in many neurological disorders, including
Parkinson’s disease, schizophrenia, Tourette’s syndrome, depres-
sion and addiction. Importantly, studies using positron emission
topography (PET) have consistently shown that nicotine [1],
heroin [2], alcohol [3], [4], methamphetamine [5] and cocaine
[6,7] abuse are accompanied by a decrease in striatal D2 receptor
(D2R) availability. Indeed, drug-induced loss of D2R is apparent
across multiple species including rodents [8], primates [6] and
humans [2-5,7]. Furthermore, studies in drug naı ¨ve non-human
primates suggest that D2R availability is predictive of future drug
seeking behavior [6]. In addition, in socially-housed macaques,
D2R availability increases in subjects that achieve social
dominance, and is lower in the subjects that become subordinate
[9]. In this setting, the subordinate subjects with low D2R
availability exhibit significantly greater cocaine seeking than the
dominant subjects with high D2R availability. Together, these
data suggest that low D2R levels contribute to drug-seeking
behavior, whether those levels are inherently low or are decreased
due to environmental influences. However, the molecular
mechanisms that mediate loss of D2R in vivo remain unclear.
Dopamine receptor mediated signaling is extensively regulated
by numerous processes, including, endocytosis, whereby agonist
activated receptors are rapidly silenced by removal from the cell
surface to an endocytic compartment. Both the D1 and the D2
receptors can be internalized after activation by dopamine [10].
However, one important distinction between D2R and D1R is
receptor fate following endocytosis [10]. Specifically, the D1R is
rapidly recycled and, thus, returns to the cell surface where it may
bind ligand once again. In contrast, the D2R is targeted for
degradation in the lysosome through its interaction with the
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hypothesized that downregulation of D2Rs in response to cocaine,
or other drug exposure that increase dopamine levels, could arise
from a GASP-mediated postendocytic degradation of D2Rs. By
extension, we hypothesized, that disruption of GASP-1 would
interfere with cocaine-induced behavioral plasticity by preventing
D2R downregulation.
Repeated exposure to psychostimulants promotes a progressive
and long lasting enhancement of drug-induced locomotor
stimulation [12–14]. This phenomenon of ‘‘behavioral sensitiza-
tion’’ is thought to underlie aspects of addiction [14]. Many
electrophysiological and cellular neuroadaptations occur during
repeated drug use [15,16]. The precise role of dopamine in these
changes is still being vigorously debated. Nevertheless, all drugs
of abuse increase dopamine levels and, thereby, activity at the
dopamine receptors. Accordingly, here we examined the hypoth-
esis that cocaine-induced behavioral sensitization is mediated by
an alteration in the balance of excitatory D1R versus inhibitory
D2R signal transduction due to GASP-1 mediated degradation of
D2R under conditions of high dopamine tone. We demonstrate
that both D2R downregulation and sensitization to repeated
cocaine exposure is attenuated in GASP-1 KO mice. Further-
more, we found that either upregulation of D1Rs or downregu-
lation of D2Rs is associated with behavioral consequences in
response to acute cocaine exposure.
Results
To examine whether GASP-1 influenced D2R responses in vivo,
mice where the GASP-1 gene had been deleted were generated
(Fig. 1). Primary ES screening was performed by Southern (DNA)
blotting. A knock-in clone was identified as positive for
homologous recombination (with a single Neo integration) using
a probe to the 59 region of the GASP-1 gene (Fig. 1B) and a Neo
probe (Fig. 1C). These ES cells were then transfected with Cre-
recombinase and clones were identified in which exon 5 of the
GASP-1 gene, which encodes the entire open reading frame, had
been excised. These ES cells were used to generate mice with a
disruption of the GASP-1 gene. Mice deficient in GASP-1
expression appeared healthy and indistinguishable from wild type
(WT) littermates. To confirm disruption of GASP-1 expression,
brain lysates from WT, heterozygous (HET) and KO mice were
immunoblotted for GASP-1 (Fig. 1D). GASP-1 immunoreactivity
was absent in GASP-1 KOs and was reduced in HETs. Since the
gene encoding GASP-1 is on the X chromosome, no HET males
were produced.
There was no difference in locomotor response between male
WT and KO or female WT, HET or KO mice when placed in a
novel environment, nor any differences observed across genotype
and sex when mice were tested on an accelerod (data not shown),
indicating that KO mice have no gross motor coordination
abnormalities or other motor impairments that might interfere
with responses to novelty. All subsequent experiments were
performed on male WT and KO littermates, 8 to 12 weeks old.
We next examined whether disruption of GASP-1 altered
behavioral responses to cocaine. Acute cocaine sensitivity and
development of behavioral sensitization to the locomotor activat-
ing effects of cocaine (15 mg/kg, IP for 5 days) was investigated in
both WT and GASP-1 KO mice. There was no significant
difference in the locomotor activity of WT and GASP-1 KO to
acute cocaine treatment after 15 min (Fig. 2A, day 1) or 60 min
(Fig. 2B, day 1) post-injection, or at any point over the remainder
of the time course (Fig. 2C, day 1). However, GASP-1 KO mice
exhibited significantly reduced sensitization that also developed
more slowly compared to WT mice. Specifically, GASP-1 KO
mice showed significantly reduced locomotor activity compared to
WTs during the first 15 min post injection on days 3, 4 and 5
(Fig. 2A, days 3, 4 and 5, *p,0.05, **p,0.01 and ***p,0.001,
WT versus GASP-1 KO). GASP-1 KOs also exhibited signifi-
cantly reduced locomotor activity for the full 60 min time course
post-injection compared to WTs on days 4 and 5 (Fig. 2B, days 4
and 5, *p,0.05, WT versus GASP-1 KO). In addition, while WT
mice developed a sensitized response by day 3 (Fig. 2A, day 3,
##p,0.01 versus day 1), GASP-1 KO mice did not develop
sensitization until day 4 (Fig. 2A, day 4, ##p,0.01 versus day 1).
Although by day 4, both WT and GASP-1 KO mice displayed a
sensitized response, the GASP-1 KO response was significantly
blunted on all days (Fig. 2B,D *p,0.05, **p,0.01 and
***p,0.001, WT versus GASP-1 KO). Finally, while there was
no difference in stereotypic behavior between genotypes following
their initial exposure to cocaine (Fig. 2E), WT mice developed
significantly higher stereotypic behaviors when compared to
GASP-1 knockouts (Fig. 2F, ***p,0.001, **p,0.01 and
*p,0.05, WT versus GASP-1 KO). These data suggest that the
development of locomotor sensitization to repeated cocaine was
significantly attenuated in GASP-1 KO mice.
We next examined whether this paradigm of repeated cocaine
administration altered dopamine receptor number. Satura-
tion radioligand binding on striatal membranes using [
3H]-
SCH23390 revealed no significant change in D1R number in
either WT or GASP-1 KO mice following cocaine sensitization
(Fig. 3A and Table 1), consistent with the ability of this receptor
to recycle following endocytosis [10]. Repeated cocaine treat-
ment led to a 50% decrease in D2Rs (Fig. 3B) in WT mice when
compared to saline treated mice as observed by a reduction in
[
3H]-Raclopride binding (Fig. 3B and Table 1, **p,0.01, WT
Figure 1. Generation of GASP-1 knockout mice. A. Targeting vector design for generating GASP-1 KO mice. A cassette expressing the G418
resistance gene flanked by lox P sites was inserted into the intron upstream of the GASP-1 open reading frame (ORF) (intron 4) and a third loxP site
was inserted in the intron downstream of the GASP ORF (intron 5). ES cells from C57/Bl6 mice were transfected with this vector. Properly targeted
clones (see B, C) were transfected with Cre-recombinase and blastocysts from clones in which the GASP-1 ORF was disrupted were implanted into
C57/BL6 females. B, C. Southern blotting analysis identified homologous recombination and single insertion using B. 59 and C. Neo probes. D.
Immuno-detection of GASP-1 in KO mice. Whole brain lysates from WT, HET and KO mice were prepared, separated by SDS-PAGE, transferred to
nitrocellulose and immunoblotted for GASP-1 using a GASP specific antibody (upper panel) or b-Actin (lower panel) to control for protein loading.
doi:10.1371/journal.pone.0011038.g001
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D2R number in GASP-1 KO mice treated with cocaine
(#p,0.05, GASP-1 KO cocaine versus GASP-1 KO saline).
Interestingly, prior to any treatment GASP-1 KO mice had
r e d u c e dD 2 Rn u m b e r sc o m p a r e dt oW Tm i c e( * p ,0.05 WT
saline versus GASP-1 KO saline). Nevertheless, the net effect of
cocaine treatment in WT mice is a decrease in the ratio of
DR2:D1R (Table 1, 0.97 in naı ¨ve versus 0.62 in cocaine treated
mice), while in GASP-KO mice the ratio of D2R:D1R is
increased (Table 1, 0.58 in naı ¨ve GASP-1 KO mice versus
0.74 in cocaine treated mice). Together, these data suggest
that GASP-1 may mediate the degradation of the D2R in
response to repeated cocaine. They also suggest that a change in
the ratio of D2R:D1R during cocaine treatment, rather than
the absolute ratio per se, influences the expression of behavioral
sensitization.
Figure 2. GASP-1 knockout mice exhibit reduced cocaine sensitization. A-D. Cocaine sensitization in WT and GASP-1 KO mice. Mice were
injected daily (IP) with saline (WT n=27, GASP-1 KO n=25) or cocaine (15 mg/kg, WT n=29, GASP-1 KO n=30) and the distance traveled reported for
A. 15 min or B. 60 min post-injection. WT mice exhibited a sensitized locomotor response to cocaine by day 3 (WT cocaine, day 3 versus day 1,
##p,0.01 as analyzed by one-way ANOVA followed by Bonferroni multiple comparison tests between corresponding days), while GASP-1 KOs
developed a significantly lower sensitized response within this first 15 min by day 4 (GASP-KO cocaine, day 4 versus day 1 ##p,0.01 as analyzed by
one-way ANOVA followed by Bonferroni multiple comparison tests between corresponding days). GASP-1 KO mice showed significantly reduced
sensitized locomotor response to cocaine compared to WT mice on all days (GASP-1 KO cocaine versus WT cocaine where *p,0.05, **p,0.01 and
***p,0.001 as analyzed by two-way ANOVA followed by Bonferroni multiple comparison tests between corresponding days). GASP-1 KO mice
showed reduced locomotor responsiveness to cocaine after repeated treatment both 15 min (C. ***p,0.001) and 60 min post-injection (D.
*p,0.05). E, F. Stereotypic behaviors of WT and GASP-1 KO mice after 1 (E) and 5 (F) days of cocaine exposure. On day 5 there were significant
differences in stereotypy at 5, 10 and 15 min (GASP-1 KO cocaine versus WT cocaine where ***p,0.001, **p,0.01 and *p,0.05 respectively as
analyzed by two-way ANOVA followed by Bonferroni multiple comparison tests between corresponding days) post-injection between cocaine
treated genotypes. Data is presented as mean 6 S.E.M.
doi:10.1371/journal.pone.0011038.g002
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mediating locomotor sensitization to cocaine, WT mice were
pre-treated for 7 days with either saline, or the D2R-like agonist
quinpirole (IP, 0.5, 1 or 5 mg/kg), which has been shown to
promote endocytosis and downregulation of D2Rs both in vitro and
in vivo (10, 17). On day 8, all groups were injected with cocaine (IP,
20 mg/kg) and their locomotor activity was examined. Only mice
pre-treated with the highest (5 mg/kg) dose of quinpirole showed
significantly higher rates of locomotion in response to acute
cocaine when compared to saline treated mice (Fig. 4A,
***p,0.001 versus saline pretreatment) and a significant decrease
in D2R number (data not shown). For this reason, the 5 mg/kg
dose was used in all subsequent experiments.
WT mice were treated once per day for 7 days with 5 mg/kg
quinpirole and locomotion was monitored each day. On days 1
and 2, quinpirole decreased the locomotor responses of WT mice
when compared to saline treated mice (Fig. 4B, ***p,0.001 and
*p,0.05 respectively), which is consistent with previous reports of
the locomotor inhibitory effects of D2R agonists [17,18].
However, by day 3, there was no longer a significant effect of
quinpirole on locomotion compared to saline (Fig. 4B). In
addition, by day 4, the locomoter response to quinpirole was
significantly reduced compared to the effect on day 1, suggesting
that the mice had become tolerant to the locomotor-supressing
effects of this drug (Fig. 4B, #p,0.05 qunipirole day 1 versus day
4, ###p,0.001 day 1 versus days 6 and 7).
On day 8, all mice (both saline and quinpirole treated) were
injected with cocaine (IP, 20 mg/kg). Consistent with our
hypothesis that D2R downregulation contributes to cocaine
sensitization, mice pretreated with quinpirole showed significantly
greater cocaine-induced locomotor activity (Fig. 4C) and stereo-
typic behavior (Fig. 4D) compared to mice pretreated with saline
(***p,0.001, **p,0.01 and *p,0.05). Saline treated mice in this
experiment showed reduced locomotion in response to acute
cocaine compared to naı ¨ve mice in the previous experiment
(Fig. 2). This can likely be attributed to a loss in novelty of the
locomotor chamber environment in this but not the previous
experiment. Here, mice were exposed to the locomotor boxes for
two habituation sessions and then each treatment day to monitor
tolerance to quinpirole (Fig. 4B), whereas mice in Figure 2
experienced only two habituation sessions in the locomotor box
before the cocaine treatment day. Despite this loss of novelty,
quinpirole pre-treatment induced significantly higher locomotor
activity to acute cocaine compared to saline pretreatment (Fig. 4C,
***p,0.001, **p,0.01 and *p,0.05).
Finally, radioligand binding in striatal membranes obtained
from the mice from Figure 4 after day 8, demonstrated that
quinpirole pretreatment promoted downregulation of D2Rs when
compared to saline treated mice, while D1R number was
unchanged, thus shifting the D2R:D1R ratio from 0.99 to 0.56
(Table 2, *p,0.05 quinpirole pretreated versus saline pretreated).
Recent evidence has suggested that many clinically important
antipsychotics behave as inverse agonists at the D2R rather than
neutral antagonists as first thought [19]. One clinically important
dopamine receptor drug, aripiprizole, is a partial agonist, rather
than an inverse agonist/neutral antagonist. Unlike the full agonists
quinpirole and dopamine, aripiprizole does not recruit b-arrestin 2
Figure 3. Reduced D2 receptor number in WT mice treated with
cocaine. A. D1R number in striatal membranes was not affected by
cocaine treatment in either genotype when assessed by saturation
binding using [
3H]-SCH23390. B. Cocaine treatment reduced D2R
number in WT mice (**p,0.01 WT cocaine versus WT saline). Saline
treated GASP-1 KO showed reduced D2R number (GASP-1 KO saline
versus WT saline where *p,0.05) and D2R number was increased in
cocaine treated GASP-1 KO mice (#p,0.05 GASP-1 KO cocaine versus
GASP-1 KO saline). D2R number was assessed by saturation binding
using [
3H]-raclopride. Data shown are normalized to saline treated
groups and are from three independent radioligand binding experi-
ments, performed in duplicate, with at least eight mice per group.
doi:10.1371/journal.pone.0011038.g003
Table 1. Bmax values and D2R:D1R ratios of WT and KO mice
saline or cocaine treated.
Bmax fmol/mg
WT KO
D1 receptor
saline 4.14160.26 4.43260.67
cocaine 3.57160.56 4.10060.67
D2 receptor
saline 4.01361.47 2.58860.72
cocaine 2.21860.03 3.04960.80
D2R:D1R ratio
saline 0.97 0.58
cocaine 0.62 0.74
Bmax values were calculated from at least three independent radioligand
binding experiments performed in duplicate with pooled striata from at least 8
mice per group. Statistical analyses are shown in Figure 3.
doi:10.1371/journal.pone.0011038.t001
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Furthermore, in vivo, aripiprazole was found to attenuate cocaine
self-administration and did not support self-administration when
given alone [22]. Therefore, we hypothesized the failure of
aripiprazole to internalize D2Rs would reduce the likelihood of
D2R downregulation and would therefore not produce a sensitized
locomotor response to acute cocaine exposure.
In agreement with previous studies, aripiprazole did not
promote endocytosis of D2Rs in vitro [21], whereas quinpirole
did [10] (Fig. 5A). WT mice were treated with vehicle or with
aripiprazole (5 mg/kg) for 7 days. On day 1, aripiprazole
decreased the locomotor responses of WT mice when compared
to vehicle treated mice (Fig. 5B). In contrast to quinpirole (Fig. 4B),
aripiprazole maintained locomotor inhibition across all days
(Fig. 5B) (***p,0.001 and *p,0.01, saline treated mice versus
aripiprazole treated mice), and showed no significant changes in
locomotor inhibition across days compared to aripiprazole
treatment on day 1. Hence, mice became tolerant to the
locomotor inhibitory effects of quinpirole (Fig. 4B) but not
aripriprizole (Fig. 5B).
On day 8, all mice were injected with cocaine (IP, 20 mg/kg).
Mice pretreated with aripiprazole (Fig. 5C) showed similar
increases in the locomotor responses to acute cocaine as mice
pretreated with quinpirole (Fig. 4C). Aripiprizole pretreated mice
showed significantly greater cocaine-induced locomotor activity
(Fig. 5C) and stereotypic behavior (Fig. 5D) compared to mice
pretreated with vehicle (***p,0.001 and **p,0.01). This was
unexpected, since D2Rs neither recruit arrestins nor internalize in
response to aripiprazole in vitro [20,21], and we predicted that the
failure of the mice to become tolerant to the locomotor inhibitory
effects of aripiprizole (Fig. 5B) reflected that D2Rs had not been
downregulated in vivo.
Indeed, radioligand binding in striatal membranes obtained
from the mice in Figure 5 after day 8, demonstrated that
aripiprazole pretreatment promoted no significant downregulation
of D2Rs (Table 2) as expected. However, aripiprazole treatment
did produce an unexpected upregulation of D1Rs changing the
D2R:D1R from 0.99 to 0.63, which was comparable to the change
in ratio seen with quinpirole pretreatment (Table 2, *p,0.05,
aripiprazole pretreated versus vehicle pretreated).
Figure 4. Repeated quinpirole treatment augmented cocaine-induced behavioral responding. A, Dose response of quinpirole
pretreatment. WT C57/BL6 mice were injected daily (IP) with saline or one of three doses of quinirole (0.5, 1 or 5 mg/kg n=8 per group) for 7 days. On
day 8 all mice were injected (IP) with 20 mg/kg cocaine and their locomotor activity recorded. B. Mice become tolerant to the locomotor-suppressing
effects of quinpirole. WT C57/BL6 mice were injected daily (IP) with saline (n=24) or quinpirole (5 mg/kg, n=24) and their locomotor activity
recorded once per day for 7 days. On days 1 and 2, quinpirole reduced locomotor activity when compared to saline treated animals (***p,0.001 and
*p,0.05 respectively). WT mice became tolerant to the locomotor inhibitory effects of quinpirole on day 4 and remained so for days 6 and 7
compared to day 1 (#p,0.05 and ###p,0.001 respectively). C, D. Repeated quinpirole pre-treatment augments locomotor response to acute
cocaine. On day 8, mice from (B) were injected with cocaine (IP, 20 mg/kg) and their locomotor activity (D) and stereotypy (E) recorded. Mice
pretreated with repeated quinpirole showed enhanced locomotor and stereotypic responses to acute cocaine compared to saline treated mice
(***p,0.001, **p,0.01 and *p,0.05). Data was analyzed by either one or two-way ANOVA with Bonferroni multiple comparison tests and presented
as mean 6 S.E.M.
doi:10.1371/journal.pone.0011038.g004
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Receptor downregulation has long been implicated in adaptive
responses to continued pharmacological stimuli. Here, we
demonstrate that preventing GASP-1-mediated downregulation
of D2Rs is associated with delays in the development of
sensitization to the locomotor activating effects of cocaine. In
addition, we show that downregulation of D2Rs, or upregulation
of D1Rs via repeated dopamine receptor agonist treatment,
significantly augments the acute locomotor response to acute
cocaine exposure. Thus, we propose sensitization to cocaine
reflects a change in the balance of D1-like versus D2-like
dopaminergic signaling in favour of the stimulatory D1-Gs/olf
pathway. Sensitization is thought to underlie at least some aspects
of addiction [12,14]. Thus, our hypothesis is consistent with
reports that reduced signaling through Gi/o is a contributing factor
in cocaine addiction [23–25]. However, while we favor this
hypothesis, we cannot rule out that the three independent
manipulations utilized here (disruption of GASP-1, treatment
with quinpirole, treatment with aripiprizole), each of which affects
the ratio of D2R:D1R, is influencing sensitization to cocaine by a
mechanism(s) other than altering this ratio.
Systemic D1R antagonists block both the development [26] and
the expression [27,28] of sensitization. Hence, D1Rs, due to their
coupling to Gs/olf, could possibly mediate some of the locomotor
stimulating effects of dopamine. Indeed, acute, D1R-selective
agonists promote locomotor activity [29] while D2R-selective
agonists inhibit locomotor activity[30]. Therefore, under condi-
tions of normal dopamine tone, the stimulatory effects of
dopamine at the D1-Gs/olf-coupled receptors are in balance with
the inhibitory effects of D2-Gi-coupled receptors. Under these
conditions, the D1-like receptors (D1R and D5R) would be
expected to endocytose and recycle, while the D2-like receptors
(D2R, D3R and D4R) would be expected to show very little
endocytosis, due to low receptor occupancy. However, under
conditions of high dopamine tone (such as during cocaine-
mediated blockade of dopamine reuptake), the occupancy, and
therefore endocytic rate of all receptors would increase. Subse-
quently, endocytosed D1Rs would continue to recycle, but
endocytosed D2Rs would be targeted for degradation via GASP-
1. Consequently, the ratio of D1R versus D2R would be shifted
towards D1R, especially under conditions of high D2R occupancy.
Antagonists at the D2R would be expected to prevent
downregulation of D2Rs by preventing their internalization in
response to dopamine [10,31]. Consistent with this hypothesis,
D2R antagonists block the development [16] but not the
expression [13] of cocaine sensitization. This change in the
balance of D1R and D2R signaling is only one of a plethora of
changes that have been shown to occur during repeated drug use.
For example, cocaine also increases extracellular glutamate levels.
Interestingly, cocaine-induced increases in glutamate appear to be
dependent on D1R action [32,33], placing this change down-
stream of the activity at the dopamine receptors.
Recently it was reported that GASP-1 may be involved in the
recycling rather than degradation of the D2R, since not only WT
but also GASP-1 KO mice showed reduced D2R number
following cocaine self-administration [34]. The reason for this
difference remains unclear but could be due to several factors.
First, our mice were generated in a pure C57Bl/6J background
while the mice in [34] are on a mixed 129S2/SvPas/C57Bl/6J
background. Hence, variation in genetic background among the
mice in could account for differences in D1 and/or D2 receptor
numbers. Furthermore, in [34], mice were sacrificed 60 minutes
after the last injection of cocaine rather then 24 hours later as in
our experiments. Therefore, the possibility remains that the
reduction in D2R number reported in mice self-administering
cocaine could be due to receptors having been endocytosed (and
thus lost from the membrane preparation) but not yet recycled in
the GASP-1 KO mice. Furthermore, spiperone, which was used as
the radioligand in [34] recognizes D2R and D4R to a similar
extent (Ki 0.06 nM and 0.08 nM respectively) but also has affinity
at 5-HT receptors, while raclopride (used in this study) shows
increased specificity for D2Rs over D3Rs and D4Rs (Ki 1.8 nM,
3.5 nM and 2400 nM respectively), and little affinity at 5-HT
receptors. In addition, substantial downregulation of D2Rs was
observed in [34] only in GASP-1 KO mice who had learned to
self-administer cocaine, not during sensitization. Currently, it is
unknown whether the learning necessary to acquire this task alters
the levels of striatal D1 and D2Rs.
Importantly, in vitro, GASP-1 specifically binds to GPCRs that
show pronounced proteolysis following prolonged agonist treat-
ment (i.e. DOR [11], CB1 [35], bradykinin B1R ([36]) and D2R
[10]). In addition, the inhibition of GASP-1 function by either over
expression of the dominant negative version of GASP-1, cGASP,
or interfering with the interaction of D2R with GASP using an
inhibitory antibody, facilitated recycling and recovery of D2R
responses rather than enhanced downregulation [10]. Together
these data suggest that GASP-1 contributes to receptor degrada-
tion. Perhaps surprisingly, we found that GASP-1 KO mice show
lower (rather than higher) baseline levels of D2Rs. These lower
levels of D2R (and thus a lower baseline ratio of D2R:D1R) did
not significantly affect acute locomotor responses to cocaine,
suggesting that it is the net change in the ratio of D2R:D1R rather
than the absolute ratio that is associated with a sensitized
locomoter response. Intriguingly, we recently found that baseline
levels of the CB1 cannabinoid receptor, which is also targeted for
degradation by GASP-1 [35], were also lower in GASP-1 KO
mice [37]. Thus, we propose that other cellular mechanisms that
regulate receptor expression levels, perhaps decreased synthesis or
Table 2. Bmax values and D2R:D1R ratios of WT mice
pretreated with quinpirole or aripiprazole.
Bmax fmol/mg
D1 receptor
Saline 3.41160.32
Vehicle 3.42360.34
Quinpirole 3.57760.14
Aripiprazole 4.29560.28 *
D2 receptor
Saline 3.36160.77
Vehicle 3.44160.11
Quinpirole 2.10860.72 *
Aripiprazole 2.72060.47
D2R:D1R ratio
Saline 0.99
Vehicle 1.01
Quinpirole 0.59
Aripiprazole 0.63
Bmax values were calculated from three independent radioligand binding
experiments performed in duplicate with 8 mice per group where quinpirole
and aripiprazole were compared against their controls (saline and vehicle
respectively, *p,0.05).
doi:10.1371/journal.pone.0011038.t002
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the GASP1 KO mice.
In conclusion, here we show that GASP-1-mediated degrada-
tion of D2Rs may be a contributing factor to cocaine-induced
behavioral sensitization and that the ratio of D1R to D2R
correlates with a change in behavioral locomotor response to acute
cocaine. Downregulation of D2Rs has been implicated in the
pathology of multiple neuropsychiatric disorders, and more than
50 drugs that target members of the dopamine receptor family
have been developed as pharmacological interventions. Impor-
tantly, for the vast majority of these ligands, the effects of the drugs
on the endocytic and postendocytic trafficking of the five distinct
dopamine receptors remains undetermined. Our studies here
clearly demonstrate that receptor trafficking can affect behavioral
outcomes in rodent models of drug-induced behavioral plasticity,
and suggest that an understanding of receptor trafficking could
provide novel insight into the therapeutic utility of future
pharmacological therapies.
Figure 5. Repeated aripiprazole treatment augmented cocaine-induced behavioral responding. A. Aripiprazole does not induce
endocytosis of D2Rs. HEK 293 cells stably expressing N-terminal FLAG-tagged D2Rs were incubated with M1 antibody to the extracellular tag for
20 mins then stimulated with quinpirole or aripiprazole (10 mM), or left untreated for 30 mins. Cells were fixed, blocked, permeabilised and receptors
visualized with fluorescent secondary antibody Alexa 488. Quinpirole but not aripiprazole induced endocytosis of the D2R. B. Acute aripiprazole
inhibits locomotion. WT C57/BL6 mice were injected daily (IP) with vehicle (n=24) or aripiprazole (5 mg/kg, n=24) and their locomotor activity
recorded once per day for 7 days. Aripiprazole reduced locomotor activity when compared to vehicle treated animals across all 7 days (*p,0.05,
***p,0.001) and there was no significant change in the effect of aripiprazole and any day compared to day 1. C, D. Repeated aripiprazole
pretreatment augments locomotor response to acute cocaine. On day 8, mice from (B) were injected with cocaine (IP, 20 mg/kg) and their locomotor
activity (D) and stereotypy (E) recorded. Mice pretreated with repeated aripiprazole showed enhanced locomotor and stereotypic responses to acute
cocaine compared to saline treated mice (***p,0.001, **p,0.01 and *p,0.05). Data was analyzed by either one or two-way ANOVA with Bonferroni
multiple comparison tests and presented as mean 6 S.E.M.
doi:10.1371/journal.pone.0011038.g005
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Animals
Mice were housed according to sex and genotype, 4 per cage
and maintained on a 12 hour light:dark cycle (lights on at 7:00am)
with continuous access to food and water.
Drugs
Cocaine hydrochloride and (-)-quinpirole hydrochloride were
purchased from Sigma Aldrich (St Louis, MO) and diluted in
isotonic saline (0.9% sodium chloride). Aripiprazole was diluted in
saline containing 1% Tween 20. All drugs were administered
intraperitoneally (IP).
Generation of GASP-1 Knockout mice
A targeting vector containing a neomycin resistance gene
flanked by lox P Cre-recombination sites were inserted into the
intron downstream of the GASP open reading frame (ORF)
(intron 5). A third lox P site was inserted in the intron upstream of
the GASP ORF. 30 mg of Not I-linearized knock-out (KO) vector
DNA was electroporated into ,10
7 C57Bl/6 embryonic stem (ES)
cells and selected with 200 mg/ml G418. Primary ES screening
was performed by Southern blotting. The selected homologous
recombinants were further transfected with a vector encoding Cre-
recombinase to selectively excise the GASP-1 gene. ES cells
deficient in GASP-1 were identified and blastocysts from these
cells implanted into C57Bl/6J females.
Locomotor Activity
Locomotor activity was monitored in an open field box (20 cm
620 cm620 cm) with a Digiscan analyser (Accuscan Instruments
Inc, Columbus, OH) where distance travelled was determined by
consecutive breaking of adjacent photo beams. Stereotypy was
estimated as repeated breaking of the same photocell beam.
Animals were habituated to the open field for 30 min prior to
injection and their activity recorded for 60 min post-drug
treatment. Animals received saline injections (ml/kg) for 2 days
prior to the start of drug or vehicle treatment to habituate them to
handling and injection procedures.
GASP detection in brain lysates
Brain lysates from wild type (WT), heterozygous (HET) and KO
mice were separated on a 4–20% gradient Tris?HCl precast gel
(Invitrogen, Carlsbad, CA) and transferred to 0.22 mm nitrocel-
lulose at 200 mA for 4 h. Blots were cut below the 75-kDa marker
band and were separately probed for b-Actin (lower blot) or GASP
(upper blot). GASP blots were incubated for 1 h with rabbit anti-
GASP (1:1,000, 5% milk, [10]) and for 1 h with HRP-conjugated
anti-rabbit secondary antibody (NEB, Ipswich, MA) (1:4,000, 5%
milk (Carnation, Nestle, Switzerland), 1 h at room temperature),
then visualized with ECL plus (Amersham Pharmacia). b-Actin
blots were incubated for 1 h with mouse anti- b-Actin (1:10,000,
5% milk) and for 1 h with HRP-conjugated anti-mouse secondary
antibody (1:4,000, 5% milk at room temperature) and visualized
with ECL plus.
Radioligand binding
24 hours after the last drug administration, mice were sacrificed
by cervical dislocation and their striatum harvested for analysis of
D1R and D2R. Striatal tissue from 4–8 mice were pooled and
homogenized in 0.32M ice cold sucrose. Samples were centrifuged
at 40,000rpm for 20 min and resuspended in 0.32M ice cold
sucrose. This step was repeated twice, and the final pellet frozen at
220uC until use. Protein concentration was determined by Bio-
Rad protein assay (Bio-Rad, Hercules, CA).
D1R number was measured using [
3H]-N-methyl-SCH23390
([
3H]-SCH23390, 85 Ci/mmol, Perkin Elmer, Boston, MA).
Total homogenates corresponding to 20 mg protein were prepared
in binding buffer containing 50 mM Tris-HCl pH 7.4, 1 mM
CaCl2, 5 mM MgCl2, 5 mM KCl, 120 mM NaCl and 0.078 nM–
20 nM [
3H]-SCH23390 in a final volume of 200 ml. Samples were
incubated for 60 minutes at 37uC and filtered through Whatman
GF/C filters that had been pretreated with 0.3% Poly(ethylenei-
mine) (PEI, Sigma). The filters were washed three times in ice cold
binding buffer and dried overnight at room temperature. The
filters were then incubated overnight in 50 ml of scintillation fluid
(Microscint 20, Perkin Elmer) prior to counting in a Packard cell
top scintillation counter (Perkin Elmer). Specific binding was
calculated as total minus nonspecific binding performed in the
presence of cold SCH23390 (20 mM). D2R number was deter-
mined using [
3H]-Methoxy-raclopride ([
3H] -Raclopride 62.2 Ci/
mmol, from Perkin Elmer) and binding performed as for the D1R.
Nonspecific binding was determined in the presence of 20 mM
cold raclopride.
Cell culture and Immunocytochemistry
Human embryonic kidney (HEK) 293 cells (American Type
Culture Collection) were grown in DMEM (Invitrogen) supple-
mented with 10% fetal bovine serum (HyClone). N-terminal
FLAG-tagged D2Rs were stably expressed in HEK293 cells. For
generation of clonal stable cell lines, single colonies were chosen
and propagated in the presence of selection-containing media. For
immunocytochemistry experiments, cells stably expressing FLAG-
tagged D2Rs were grown on coverslips to 50% confluency. Live
cells were fed M1 antibody (Sigma) directed against the FLAG tag
(1:1,000, 30 min). Cells were then treated with agonist (10 mM
quinpirole or 10 mM aripiprazole) for 30 min or left untreated.
Cells were then fixed with 4% formaldehyde in PBS. After
fixation, cells were permeabilized in blotto with 0.1% Triton X-
100 and stained with fluorescently conjugated secondary antibody
(1:500, Molecular Probes).
Statistical Analyses
Data were analyzed using one or two way analysis of variance
(ANOVA) followed by Bonferroni multiple comparisons 6 S.E.M.
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